WHO ICTRP trial
An Open-label, Phase I Study to determine the Safety and Pharmacokinetics of…
NL-OMON29756 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON29756 |
|---|---|
| Public title | An Open-label, Phase I Study to determine the Safety and Pharmacokinetics of JNJ-26483327, a Multi-targeted Kinase Inhibitor, administered to Subjects with Advanced Stage and/or Refractory Solid Malignancies |
| Scientific title | An Open-label, Phase I Study to determine the Safety and Pharmacokinetics of JNJ-26483327, a Multi-targeted Kinase Inhibitor, administered to Subjects with Advanced Stage and/or Refractory Solid Malignancies - Dose escalation safety and Pharmacokinetic study. |
| Primary sponsor | Johnson & Johnson Pharmaceutical |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | cancer;10027655;cancer |
| Interventions | not applicable ;JNJ26483327;Patients with advanced cancer;Pharmacokinetics;Safety |
| Registration date | Sep 6, 2006 |
| Target size | 50 |
| Secondary IDs | 2006-000593-69;NL12616.078.06 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: